Longduoduo Co Ltd (LDDD): Cost of Revenue
$17.0K
Year ended 2026-06-30
-69.4%
3-year compound annual growth
-29.0%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $17.0K | -81.4% | 2026-09-30, From 2025-07-01 |
| 2025-06-30 | $91.1K | -47.4% | 2026-09-30, From 2024-07-01 |
| 2024-06-30 | $173.3K | -70.7% | 2025-09-26, From 2023-07-01 |
| 2023-06-30 | $591.9K | -41.1% | 2024-10-15, From 2022-07-01 |
| 2022-06-30 | $1.01M | +966.5% | 2023-11-14, From 2021-07-01 |
| 2021-06-30 | $94.2K | n/a | 2022-10-13, From 2020-07-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Longduoduo Co Ltd (LDDD) | 2026-06-30 | $17.0K | -81.4% |
| Agape ATP Corp (ATPC) | 2025-12-31 | $686.0K | +21.7% |
| EUDA Health Holdings Ltd (EUDA) | 2025-12-31 | $3.83M | +17.8% |
| Vsee Health, Inc. (VSEE) | 2025-12-31 | $7.26M | +123.9% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | $156.01M | +33.1% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $89.27M | +33.4% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $129.37M | +16.5% |
Compare LDDD, ATPC, EUDA, VSEE side by side · Screen every company in Services-Health Services ↗